Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial